UCM1400
UCM1400 is a melatonin receptor (MT) subtype-selective modulator. It acts as an agonist on MT1 with a pKi value of 7.94 and as an antagonist on MT2 with a pKi value of 8.11. UCM1400 inhibits MT2 receptor-mediated reduction of cyclic adenosine monophosphate (cAMP) with a pIC50 value of 7.87. It exhibits antiproliferative activity on human glioma cells and inhibits tumor growth, making it a potential candidate for cancer research, including studies on gliomas.
Product Specifications
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
A33313-Dylight594 100 µg
Anti-LY6C Antibody Picoband®, Dylight594 Conjugate
Sign In for Pricing
View Details MBS1144291-01 0.02 mg (E-Coli)
Recombinant Wolbachia pipientis subsp. Culex pipiens Dihydrodipicolinate reductase (dapB)
Sign In for Pricing
View Details MBS1144291-02 0.02 mg (Yeast)
Recombinant Wolbachia pipientis subsp. Culex pipiens Dihydrodipicolinate reductase (dapB)
Sign In for Pricing
View Details MBS1144291-03 0.1 mg (E-Coli)
Recombinant Wolbachia pipientis subsp. Culex pipiens Dihydrodipicolinate reductase (dapB)
Sign In for Pricing
View Details MBS1144291-04 0.1 mg (Yeast)
Recombinant Wolbachia pipientis subsp. Culex pipiens Dihydrodipicolinate reductase (dapB)
Sign In for Pricing
View Details MBS1144291-05 0.02 mg (Baculovirus)
Recombinant Wolbachia pipientis subsp. Culex pipiens Dihydrodipicolinate reductase (dapB)
Sign In for Pricing
View Details